Rabbit antithymocyte globulin for the treatment of chronic lung allograft dysfunction.
Spenser E JanuaryKeith A FesterKaren Bennett BainHrishikesh S KulkarniChad A WittDerek E ByersJennifer Alexander-BrettElbert P TrulockRamsey R HachemPublished in: Clinical transplantation (2019)
40% of patients with CLAD have an improvement in lung function after treatment with rATG although the improvement was typically minimal.